AKT2 and exocrine pancreatic carcinoma: Indeed, AKT2 is amplified and overexpressed in pancreatic carcinomas and AKT2 antisense RNA can greatly diminish the tumorigenic phenotype of pancreatic cancer cells harboring amplified AKT2 [44].